Search Results - "Bilitou, A"

Simulation study on LDL cholesterol target attainment, ASCVD events, and treatment cost of bempedoic acid in a representative German cohort of high- and very-high-CV risk patients by Katzmann, J, Becker, C, Bilitou, A, Laufs, U

“…Abstract Background The LDL cholesterol (LDL-C) treatment goals recommended by the 2019 ESC/EAS guidelines are only achieved in a minority of patients. For…”
Get full text

Importance of baseline LDL-C in the association between LDL-C lowering and cardiovascular risk: A meta-regression analysis by Hawe, E., Meleth, S., Wolowacz, S., Bilitou, A.

Get full text

Treatment of high- and very high-risk patients for the prevention of cardiovascular events in Europe: baseline demographics from the multinational observational SANTORINI study by Ray, K K, Haq, I, Bilitou, A, Catapano, A L

“…Abstract Background The ESC/EAS 2019 guidelines recommend ambitious lower goals for low-density lipoprotein cholesterol (LDL-C), especially for patients with…”
Get full text

A structured literature review of real world evidence reflecting the current lipid management across Europe by Anastassopoulou, A., Bilitou, A., Soronen, J., Barrios, V.

Get full text

The prevalence and patient outcomes of adult primary hypercholesterolaemia and dyslipidaemia in the UK: a longitudinal retrospective study using a primary care dataset from 2008 to 2018 by Bilitou, A, Rabe, A, Inema, L, Alamgir, G, Dunton, K

“…Abstract Background Cardiovascular disease (CVD) remains the leading cause of death and morbidity in Europe and United Kingdom (UK). Increased low-density…”
Get full text

Simulation of bempedoic acid in the lipid-lowering treatment pathway using the European contemporary SANTORINI cohort of high- and very high-risk patients by Ray, K K, Catapano, A L, Diamand, F, Wolowacz, S, Haq, I, Bilitou, A

“…Abstract Background Lowering LDL-C treatment goals in the 2019 ESC/EAS guidelines necessitates greater use of combination therapies (1). Cost of PCSK9…”
Get full text

Cardiovascular risk assessment by physicians and lipid-lowering therapy prescribing in high- and very high-risk patients: Results from the multinational observational santorini study by Ray, K.K., Haq, I., Bilitou, A., Manu, M.C., Burden, A., Catapano, A.L.

Get full text

Baseline characteristics and management of high- and very high-risk patients with hypercholesterolemia or mixed dyslipidemia in the multinational observational SANTORINI study by Ray, K.K., Haq, I., Bilitou, A., Manu, M.C., Burden, A., Catapano, A.L.

Get full text

Treatment patterns and healthcare resource use in primary hypercholesterolaemia and mixed dyslipidaemia: Results of a UK Delphi panel by Llewellyn, S., Bilitou, A., Dunton, K., Åkesson, C., Hall, K., Quinn, C.

Get full text

POSB70 Systematic Literature Review of Cost and Data Sources for Economic Evaluations in Hypercholesterolaemia and Mixed Dyslipidaemia from a UK Perspective by Spentzouris, G, Bilitou, A, Manga, N, McCrink, L, Pearson, I, Mitchell, S, Moss, E, Rothwell, B

Get full text

POSB2 A Targeted Review of Published Meta-Analyses for LDL-C Lowering Treatments Beyond Statins: Bempedoic Acid, Ezetimibe, and PCSK9-Inhibitors Including Inclisiran by Van Schoonhoven, A, Spentzouris, G, Westerink, L, Tiemens, A, Bilitou, A, Postma, M

Get full text

Treatment gaps in the implementation of LDL cholesterol control among high- and very high-risk patients in Europe between 2020 and 2021: the multinational observational SANTORINI study by Ray, Kausik K., Haq, Inaam, Bilitou, Aikaterini, Manu, Marius C., Burden, Annie, Aguiar, Carlos, Arca, Marcello, Connolly, Derek L., Eriksson, Mats, Ferrières, Jean, Laufs, Ulrich, Mostaza, Jose M., Nanchen, David, Rietzschel, Ernst, Strandberg, Timo, Toplak, Hermann, Visseren, Frank L.J., Catapano, Alberico L.

“…European data pre-2019 suggest statin monotherapy is the most common approach to lipid management for preventing cardiovascular (CV) events, resulting in only…”
Get full text

CV4 Patients with Hypercholesterolaemia or MIXED Dyslipidaemia and High or VERY High Cardiovascular Risk According to ESC/EAS Guidelines – a Population-Based CROSS–Sectional Study from the Netherlands by Heintjes, E., Kuiper, J., Anastassopoulou, A., Penning-van Beest, F., Bilitou, A., Kerschnitzki, M., Herings, R., Postma, M., Jukema, J.

Get full text

PND121 - UTILITIES ASSOCIATED WITH ATTRIBUTES OF MIGRAINE PREVENTIVE TREATMENTS: ROUTE OF ADMINISTRATION AND ADVERSE EVENTS by Matza, LS, Deger, K, Vo, P, Maniyar, F, Bilitou, A, Goadsby, PJ

Get full text

Prevalence and Patient Outcomes of Adult Primary Hypercholesterolemia and Dyslipidemia in the UK: Longitudinal Retrospective Study Using a Primary Care Dataset from 2009 to 2019 by Bilitou, Aikaterini, Were, John, Farrer, Archie, Rabe, Adrian, Ming, Simon Wan Yau, Haq, Inaam, Dunton, Kyle

“…Guidelines for the management of dyslipidemias recommend intensive low-density lipoprotein (LDL-C) control through lifestyle advice and lipid-lowering drugs to…”
Get full text

PND9 - MIGRAINE BURDEN BEFORE AND AFTER ERENUMAB TREATMENT: A RESPONDER ANALYSIS IN DIFFICULT-TO-TREAT PATIENTS by Huels, J, Bilitou, A, Vo, P, de Reydet de Vulpillieres, F., Mahon, R, Cooney, P, Lopez Lopez, C

Get full text

Evaluation of contemporary treatment of high- and very high-risk patients for the prevention of cardiovascular events in Europe – Methodology and rationale for the multinational observational SANTORINI study by Ray, Kausik K., Haq, Inaam, Bilitou, Aikaterini, Aguiar, Carlos, Arca, Marcello, Connolly, Derek L., Eriksson, Mats, Ferrières, Jean, Hildebrandt, Per, Laufs, Ulrich, Mostaza, Jose M., Nanchen, David, Rietzschel, Ernst, Strandberg, Timo, Toplak, Hermann, Visseren, Frank L.J., Catapano, Alberico L.

“…Clinical practice before 2019 suggests a substantial proportion of high and very high CV risk patients taking lipid-lowering therapy (LLT) would not achieve…”
Get full text

Cost-effectiveness of eplerenone in NYHA class II chronic heart failure patients with reduced LVEF: an analysis for Greece by Athanasakis, Kostas, Bilitou, Aikaterini, Lee, Dawn, Karampli, Eleftheria, Karavidas, Apostolos, Parissis, John, Sykara, Georgia, Kyriopoulos, John

“…The aim of the study was to evaluate the cost-effectiveness (CE) of treatment with eplerenone versus standard care in adult patients with New York Heart…”
Get full text